Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kenneth J. Zuerblis currently holds 60,121 shares of STEMLINE THERAPEUTICS INC (STML), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth J. Zuerblis has been a net buyer of STML stock. They have purchased $84.1K and sold $0 worth of shares.
Kenneth J. Zuerblis's most recent insider trade was on Jun 10, 2020, when they sold 60,121 shares at $0.00 per share.
Kenneth J. Zuerblis serves as Executive at STEMLINE THERAPEUTICS INC (STML). They have executed 16 insider transactions totaling $84.1K over their tenure at the company.
Kenneth J. Zuerblis holds the position of Executive at STEMLINE THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Kenneth J. Zuerblis has shown a buying trading pattern, with $84.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Kenneth J. Zuerblis was on Sep 15, 2011, when they purchased $16.2K worth of SVNT shares. This transaction involved 4,000 shares at $4.05 per share.
Kenneth J. Zuerblis currently owns 60,121 shares of STEMLINE THERAPEUTICS INC (STML), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kenneth J. Zuerblis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kenneth J. Zuerblis has 16 Form 4 filings on record as an insider at STEMLINE THERAPEUTICS INC.
Set alerts for Kenneth J. Zuerblis and 40,000+ other insiders.